The US Food and Drug Administration and the Federal Trade Commission have issued an alert to the public concerning the growing availability of web sites offering products that can supposedly diagnose, prevent, mitigate, treat or cure the H1N1 swine influenza. The two federal government agencies also warned the operators of offending Internet domains that "they must take prompt action to correct and/or remove promotions of these fraudulent products or face enforcement action."
Michael Chappell, the FDA's Acting Commissioner for Regulatory Affairs said: "in conjunction with the Federal Trade Commission, the FDA has developed an aggressive strategy to identify, investigate and take regulatory or criminal action against individuals or businesses that wrongfully promote purported 2009 H1N1 influenza products in an attempt to take advantage of the current public health emergency." Mr Chappell stressed that unlicensed products advertised on-line present a risk to consumers and their families. The FDA operates a web site providing advice for the purchase of medicines via the Internet, which can be found at: www.fda.gov/buyonlineguide.
The FTC Chairman, Jon Leibowitz, said: "the last thing any consumer needs right now is to be conned by someone selling fraudulent flu remedies." He added that "the FTC will act swiftly against companies that resort to deceptive advertising."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze